BenevolentAI hires Ian Churcher as VP of Drug Discovery & Preclinical Development August 25, 2017 CenterWatch Staff
CRISPR, Massachusetts General Hospital partner on CRISPR/Cas9 in T cell cancer therapies August 24, 2017 CenterWatch Staff
BioLineRx plans phase III BL-8040 registrational study of stem cell mobilization August 22, 2017 CenterWatch Staff